Global Plasma Therapy Market: Overview
Blood plasma comprises platelets, autologous platelets and cytokines which arouse healing of soft tissue. It is a traditional method widely used in specialties of dentistry, dermatology and orthopedics. Plasma therapy is extensively used in wound healing, androgenetic alopecia and face rejuvenation. Plasma is concentrated up to 3–5 times of the physiological value and then injected into the tissue where healing is required.
Global Plasma Therapy Market: Growth Factors
Orthopedic disorders are linked with aging and trauma, hence high growth in demand for minimally invasive therapies is anticipated, which in turn may boost the global plasma therapy market growth. This has led to increased demand for PRP in dental applications, dermatology, orthopedic, cardiac muscle injury and nerve injury. Increasing occurrences of orthopedic disorders such as arthritis and rising healthcare expenditure are factors anticipated to foster the global market growth. A number of patients with androgenic alopecia is growing across the world and increasing incidences of sports injuries may boost the global market growth in future. Moreover, rising use of platelet-rich plasma in numerous therapeutic areas positively impacts the global plasma therapy market. However, lack of awareness regarding platelet-rich therapy, lack of reimbursement policies and stringent regulatory policies restraint the global market growth.
Global Plasma Therapy Market: Segmentation
The global plasma therapy market is classified based on the source as allogenic and autologous. The autologous segment is the leading segment globally owing to effective and safety results. Based on the type, the global market is categorized into leukocyte-rich fibrin, pure PRP, pure platelet-rich fibrin and leucocyte-rich PRP. The pure PRP segment holds the largest market share across the globe. It is highly demanding due to antimicrobial effects and high success rate. On the basis of applications, the global plasma therapy market is fragmented as nerve injury, orthopedics, dental, cardiac muscle injury and dermatology. The orthopedic segment is further sub-segmented as chronic tendinitis, bone repair & regeneration and arthritis. The dermatology segment is sub-segmented as plastic surgery and androgenic alopecia. The dermatology application segment is the dominating segment owing to higher acceptance of cosmetic procedures and growing occurrence of androgenic alopecia. Moreover, based on the end user, the global plasma therapy market is segmented as research institutes and hospitals & clinics. Of these, hospitals & clinics segment contributes for the largest share of the market.
Global Plasma Therapy Market: Regional Analysis
North America accounted for the largest market share in the global plasma therapy market. The growth is mainly attributed to increasing government support for developments in the field of plasma therapy. In addition, growing aged population also fosters the global market growth. Asia Pacific is growing at a faster rate grabbing the largest market chunk. Increasing disposable income of patients, growing medical tourism and rising healthcare awareness of practitioner are some factors responsible for the global plasma therapy market growth in Asia Pacific. Some other factors such as technological advancement and increasing government initiatives for development in plasma protein medicines also fuel market growth.
Global Plasma Therapy Market: Competitive Players
Prominent players operating in the global plasma therapy market are Octapharma, BioLife Plasma Services, Bio Products Laboratory Ltd., Kedrion S.p.A. and CSL Ltd. Other influencing players include China Biologic Products, Inc., Cambryn Biologics LLC, LFB S.A., and Grifols International S.A.
Global Plasma Therapy Market: Regional Segment Analysis
What Report Provides